Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Foghorn Therapeutics Inc.

NASDAQ: FHTX · Life Sciences · 3 alerts · CIK 1822462

Share price
$1.79Close, Nov 16
Market cap
$107M
Shares outstanding
59.96MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Foghorn Therapeutics Inc. filings on SEC EDGAR ↗

7:01 AM ET 8-K
Other 8-K Filing

Foghorn Therapeutics Other 8-K Filing

Foghorn Therapeutics and Eli Lilly have decided to discontinue the clinical development of FHD-909 and their SMARCA2 degrader collaboration following a review of Phase 1 data. Consequently, Foghorn is implementing a strategic reprioritization and a 40% workforce reduction to extend its cash runway into the second half of 2029, incurring approximately $2.3 million in severance-related charges.

Counterparty
Eli Lilly and Company

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.